Jan 31
|
Why Obesity Drug Coverage Doesn’t Matter (Yet) for Lilly and Novo
|
Jan 31
|
Novo Nordisk earnings: 'I could smile a long time over results like this,' says CFO Knudsen
|
Jan 31
|
UPDATE 2-As Lilly rivalry flares, Novo CEO sets out Wegovy launch strategy
|
Jan 31
|
As Lilly rivalry flares, Novo CEO sets out Wegovy launch strategy
|
Jan 31
|
As Lilly competition heats up, Novo CEO details strategy for new Wegovy launches
|
Jan 31
|
UPDATE 4-Novo Nordisk expects double-digit growth as it boosts Wegovy supplies
|
Jan 31
|
Weight-Loss Drug Boom Sends Novo Nordisk Profits Soaring. Why the Success Brings Challenges.
|
Jan 30
|
More reasons to go in on Eli Lilly stock, but avoid Tesla
|
Jan 30
|
Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy?
|
Jan 30
|
Is Lilly (LLY) a Buy as Wall Street Analysts Look Optimistic?
|
Jan 30
|
15 Best Dividend Paying Stocks To Buy Now
|
Jan 30
|
UPDATE 2-German health ministry: no plans for insurance coverage of weight-loss drugs
|
Jan 29
|
20 Countries With The Highest Life Expectancy in the World
|
Jan 29
|
Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to Know
|
Jan 29
|
Rise in reports of fake weight-loss drugs linked to shortage of real thing, WHO says
|
Jan 16
|
These Stocks Are Showing Relative Strength as S&P 500 Stalls Near Record High
|
Jan 16
|
Analysts Predict The 10 Most-Valuable Stocks In 12 Months
|
Jan 16
|
UPDATE 2-Lilly exec eyes more weight-loss drug launches this year
|
Jan 16
|
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
|
Jan 16
|
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
|